Alembic Pharmaceuticals Limited (APLLTD) — Board Meeting
Alembic Pharmaceuticals announced the appointment of Sujit Jaysukh Bhayani as an Additional Director and Non-Executive Independent Director effective 18 June 2026 for a five-year term, subject to shareholder approval at the upcoming AGM. The appointment follows the recommendation of the Nomination and Remuneration Committee and complies with SEBI Listing Regulations.
About Alembic Pharmaceuticals Limited (APLLTD)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when APLLTD files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track APLLTD — Free💡 Ask AI about this filing
📊 More APLLTD filings
- 🔴 Annual Report — 10 July 2026 Alembic Pharmaceuticals announced its 16th Annual General Meeting on 5 August 2026 via video confere...
- 🔴 Corporate Action — 10 July 2026 Alembic Pharmaceuticals announced a record date of 29 July 2026 for dividend entitlement on FY2026 s...
- 🔴 Announcement — 1 July 2026 Alembic Pharmaceuticals reaffirmed its CRISIL AA+/Stable rating on a revalued Rs. 1,100 crore bank l...
- Announcement — 26 June 2026 Alembic Pharmaceuticals announced USFDA final approval for Oseltamivir Phosphate Oral Suspension 6 m...
- Financial Results — 26 June 2026 Alembic Pharmaceuticals announced that its trading window will close on 1 July 2026 and remain close...
🔥 Also filed on 18 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when APLLTD files new disclosures
Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track APLLTD — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research